Modulating the immune system through nanotechnology

被引:90
作者
Dacoba, Tamara G. [1 ,2 ]
Olivera, Ana [1 ,2 ]
Torres, Dolores [2 ]
Crecente-Campo, Jose [1 ,2 ]
Jose Alonso, Maria [1 ,2 ]
机构
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Campus Vida, Santiago De Compostela 15782, Spain
[2] Univ Santiago de Compostela, Sch Pharm, Dept Pharmacol Pharm & Pharmaceut Technol, Campus Vida, Santiago De Compostela 15782, Spain
基金
美国国家卫生研究院; 欧盟地平线“2020”;
关键词
Nanotechnology; Immune system; Tolerance; Stimulation; Autoimmune disease; Vaccine; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; TUMOR-ASSOCIATED MACROPHAGES; ANTIGEN-PRESENTING CELLS; NASAL VACCINE DELIVERY; PEG-PLA NANOPARTICLES; REGULATORY T-CELLS; DENDRITIC CELLS; IN-VIVO; CROSS-PRESENTATION;
D O I
10.1016/j.smim.2017.09.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nowadays, nanotechnology-based modulation of the immune system is presented as a cutting-edge strategy, which may lead to significant improvements in the treatment of severe diseases. In particular, efforts have been focused on the development of nanotechnology-based vaccines, which could be used for immunization or generation of tolerance. In this review, we highlight how different immune responses can be elicited by tuning nanosystems properties. In addition, we discuss specific formulation approaches designed for the development of anti-infectious and anti-autoimmune vaccines, as well as those intended to prevent the formation of antibodies against biologicals.
引用
收藏
页码:78 / 102
页数:25
相关论文
共 287 条
[1]   Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy [J].
Abellan-Pose, Raquel ;
Csaba, Noemi ;
Jose Alonso, Maria .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) :1194-1209
[2]   CONTROLLED-RELEASE VACCINES - BIODEGRADABLE POLYLACTIDE POLYGLYCOLIDE (PL/PG) MICROSPHERES AS ANTIGEN VEHICLES [J].
AGUADO, MT ;
LAMBERT, PH .
IMMUNOBIOLOGY, 1992, 184 (2-3) :113-125
[3]   Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics [J].
Ahmadi, Maryam ;
Bryson, Christine J. ;
Cloake, Edward A. ;
Welch, Katie ;
Filipe, Vasco ;
Romeijn, Stefan ;
Hawe, Andrea ;
Jiskoot, Wim ;
Baker, Matthew P. ;
Fogg, Mark H. .
PHARMACEUTICAL RESEARCH, 2015, 32 (04) :1383-1394
[4]   Gold Nanoparticles Displaying Tumor-Associated Self-Antigens as a Potential Vaccine for Cancer Immunotherapy [J].
Ahn, Sukyung ;
Lee, In-Hyun ;
Kang, Sukmo ;
Kim, Daejin ;
Choi, Minsuk ;
Saw, Phei Er ;
Shin, Eui-Cheol ;
Jon, Sangyong .
ADVANCED HEALTHCARE MATERIALS, 2014, 3 (08) :1194-1199
[5]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[6]   Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system [J].
Amidi, M ;
Romeijn, SG ;
Borchard, G ;
Junginger, HE ;
Hennink, WE ;
Jiskoot, W .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :107-116
[7]  
[Anonymous], 2014, OVERVIEW JUVARIS TEC
[8]  
[Anonymous], 2014, GUID IND IMM ASS THE
[9]   Nanoparticles in the clinic [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (01) :10-29
[10]  
Arvan P., 2012, COLD SPRING HARB PER, V2